# End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia

> **NCT01386723** · — · TERMINATED · sponsor: **Weill Medical College of Cornell University** · enrollment: 35 (actual)

## Conditions studied

- Immune Thrombocytopenia

## Interventions

- **DRUG:** Discontinuation of eltrombopag

## Key facts

- **NCT ID:** NCT01386723
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2011-06
- **Primary completion:** 2017-01-31
- **Final completion:** —
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2018-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01386723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01386723, "End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01386723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*